This Month's Tiny Gems - September 2013
Advaxis, Inc. (ADXS)
Advaxis, Inc. is a clinical-stage biotechnology company developing the next-generation of immunotherapies for cancer and infectious diseases. The company’s immunotherapies are based on a novel platform technology that uses live, bio-engineered bacteria to secrete antigen/adjuvant fusion protein(s) that redirects the powerful immune response all human beings have to the bacteria to fight off cancer and disease. A second effect is to reduce the immune suppressive cells cancer tumors recruit to protect themselves from immune attack by over 80%. It is this combination that makes Advaxis special.
CytRx Corp. (NASDAQ:CYTR)
CytRx Corp., a biopharmaceutical research and development company, specializes in the enhanced delivery of proven oncology therapies to treat cancer. The company’s novel linker platform technology can be utilized with multiple chemotherapeutic agents and could allow for greater concentration of drug at tumor sites while minimizing side effects.
ForceField Energy, Inc. (FNRG)
ForceField Energy, Inc. is an international manufacturer, distributor, and licensee of alternative energy products and solutions. The company operates in three of the largest and fastest-growing areas of the global renewable energy space: industrial waste heat recovery and conversion, commercial LED lighting products, and solar cell feedstock production.
NanoString Technologies Inc. (NSTG)
Innovation is a keyword when related to NanoString Technologies. It is a corporation committed to providing the means by which scientists and clinicians are able to convert foremost research into improved patient care through clinical and actionable testing. This is achieved with their innovative product development, which enables them to reveal genomic information from limited amounts of tissue.